{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T10:59:10Z","timestamp":1757588350474,"version":"3.37.0"},"reference-count":21,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T00:00:00Z","timestamp":1237939200000},"content-version":"vor","delay-in-days":6842,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology &amp; Toxicology"],"published-print":{"date-parts":[[1990,7]]},"abstract":"<jats:p>Twenty volunteers were exposed to 191 \u00b1 7 p.p.m. 1,1,1\u2010trichloroethane or 50 \u00b1 2 p.p.m. perchloroethylene vapour for 6 hr. They were then evaluated for their rate of caffeine metabolism, mephenytoin hydroxylation and debrisoquine hydroxylation. Seven subjects were idendified as \u2018fast acetylators\u2019 of caffeine and one person as a slow metabolizer of debrisoquine. The \u201cslow acetylators\u201d exposed to perchloroethylene excreted an average of 3.83 \u00b1 0.35 mg trichloroacetic acid within 24 hr (N = 13, \u00b1 S.E.) and the \u2018fast acetylators\u2019 3.58 \u00b1 0.48 mg (N = 7, \u00b1 S.E.). The excretion of trichloroethanol by the same persons after 1,1,1\u2010trichloroethane exposure was 14.1 \u00b1 1.12 mg and 16.7 \u00b1 1.48 mg, respectively. The excretion of trichloroacetic acid in the latter exposure varied significantly between the seven \u2018fast\u2019 and 13 \u2018slow acetylators\u2019 (0.43 \u00b1 0.08 mg versus 1.03 \u00b1 0.19 mg; \u00b1 S.E.; P = 0.037). A multiple linear regression analysis confirmed this association when other factors, such as body weight, creatinine clearance, smoking habit and alcohol consumption, were taken into account. One volunteer proved to be a poor hydroxylator of debrisoquine and excreted half the amount of trichloroacetic acid in the perchloroethylene exposure and half the amount of trichloroethanol in the 1,1,1\u2010trichloroethane exposure compared to the others. A reduction in the solvent metabolism could thus be predicted by the debrisoquine test. On the other hand, the caffeine test predicted faster oxidation of trichloroethanol which could be of toxicological and pharmacological importance e.g. in the clinical use of chloral.<\/jats:p>","DOI":"10.1111\/j.1600-0773.1990.tb00779.x","type":"journal-article","created":{"date-parts":[[2009,3,25]],"date-time":"2009-03-25T17:55:36Z","timestamp":1238003736000},"page":"41-46","source":"Crossref","is-referenced-by-count":3,"title":["Demethylation Pathways in Caffeine Metabolism as Indicators of Variability in 1,1,1\u2010Trichloroethane Oxidation in Man"],"prefix":"10.1111","volume":"67","author":[{"given":"Michele","family":"Berode","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.\u2010A.","family":"Boillat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. P.","family":"Guillemin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei\u2010Miau","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Savolainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,3,25]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-197702020-00002"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(01)91772-8"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1987.126"},{"key":"e_1_2_1_5_1","first-page":"1061","article-title":"Hydroxylierungsdefekt f\u00fcr Medikamente (Typus Debrisoquin) in einer Stichprobe der schweizer Bev\u00f6lkerung","volume":"112","author":"Dick B.","year":"1984","journal-title":"Schweiz. Med. Wschr."},{"key":"e_1_2_1_6_1","first-page":"244","article-title":"The molecular biology of cytochrome P450s","volume":"40","author":"Gonzales F. J.","year":"1989","journal-title":"Pharmacol. Rev."},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1983.45"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1984.tb02372.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(87)90078-5"},{"key":"e_1_2_1_10_1","first-page":"421","article-title":"Setting\u2010up and use of an experimental chamber","volume":"36","author":"Guillemin M. P.","year":"1975","journal-title":"Arch. Mal. Prof."},{"key":"e_1_2_1_11_1","first-page":"161","article-title":"Value of the simultaneous determination of PCO2 in monitoring exposure to 1,1,1\u2010trichloroethane by breath analysis","volume":"39","author":"Guillemin M. P.","year":"1982","journal-title":"Brit. J. Ind. Med."},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00343270"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00541938"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91430-1"},{"key":"e_1_2_1_15_1","first-page":"153","article-title":"A family and population study of the genetic polymorphism of debrisoquin oxidation in a white British population","volume":"17","author":"Price E. D. A.","year":"1980","journal-title":"J. Med. Genetic."},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0006-2952(88)90423-6"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(88)90310-5"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/0013-9351(77)90061-5"},{"volume-title":"SPSS\u2010XTM user's guide","year":"1988","author":"SAS Inc.","key":"e_1_2_1_19_1"},{"key":"e_1_2_1_20_1","first-page":"2319","article-title":"New directions in pharmacogenetics","volume":"43","author":"Vessel E. S.","year":"1984","journal-title":"Fed. Proc. Fed. Am. Soc. Exp. Biol."},{"key":"e_1_2_1_21_1","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S0022-5347(25)00297-6","article-title":"Aging and drug interactions. Effect of cimetidine and smoking on the oxidation of theophylline and cortisol in healthy men","volume":"241","author":"Vestal R. E.","year":"1987","journal-title":"J. Pharmacol. Exp. Therap."},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1984.256"}],"container-title":["Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0773.1990.tb00779.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0773.1990.tb00779.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T17:37:49Z","timestamp":1739036269000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0773.1990.tb00779.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,7]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,7]]}},"alternative-id":["10.1111\/j.1600-0773.1990.tb00779.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0773.1990.tb00779.x","archive":["Portico"],"relation":{},"ISSN":["0901-9928"],"issn-type":[{"type":"print","value":"0901-9928"}],"subject":[],"published":{"date-parts":[[1990,7]]}}}